Prediction of worsening of renal function by the combination of an initial decline in renal function and blood pressure-lowering effect after renin–angiotensin system blockade in patients with type 2 diabetes mellitus (JDDM 83)
- 16 March 2026
- journal article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 40 (5) , 109309
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trialsThe Lancet Diabetes & Endocrinology, 2024
- Acute changes in glomerular filtration rate with renin-angiotensin system (RAS) inhibition: clinical implicationsKidney International, 2017
- Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomesKidney International, 2017
- Blood Pressure Lowering in Type 2 DiabetesJAMA, 2015
- Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysisThe Lancet, 2012
- Treatment of diabetic nephropathy with angiotensin II receptor antagonistClinical and Experimental Nephrology, 2003
- Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM)Diabetes Research and Clinical Practice, 2002
- Angiotensin-Converting Enzyme Inhibitor–Associated Elevations in Serum CreatinineArchives of internal medicine (1960), 2000
- Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuriaThe Lancet, 1997
- A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal functionKidney International, 1997